Larry Wood - May 7, 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
May 7, 2021
Transactions value $
-$508,791
Form type
4
Date filed
5/11/2021, 10:03 AM
Next filing
May 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Tax liability -$62.3K -679 -0.18% $91.75 368K May 7, 2021 Direct
transaction EW Common Stock Options Exercise $276K +7.83K +2.13% $35.20 376K May 10, 2021 Direct F1
transaction EW Common Stock Sale -$722K -7.83K -2.09% $92.22 368K May 10, 2021 Direct F1
holding EW Common Stock 496 May 7, 2021 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7.83K -12.5% $0.00 54.8K May 10, 2021 Common Stock 7.83K $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.
F2 Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.